文献速递乳腺MR

以表观扩散系数映射作为独立参数的扩散加权成像用于乳腺癌检测:与动态对比增强及多参数磁共振成像的比较

Diffusion-Weighted Imaging With Apparent Diffusion Coefficient Mapping for Breast Cancer Detection as a Stand-Alone Parameter: Comparison With Dynamic Contrast-Enhanced and Multiparametric Magnetic Resonance Imaging.
PubMed 文献 · Invest Radiol · 2018-01-01

单中心回顾性分析106例因影像异常行乳腺MRI的患者前瞻性采集数据,比较DWI(ADC映射作为独立参数)、DCE-MRI及两者联合的mpMRI对乳腺癌的检测效能,以组织病理为金标准。DCE-MRI平均敏感度100%最高,DWI敏感度82%较低但特异度86.8%高于DCE-MRI的76.6%,mpMRI敏感度96.8%与DCE-MRI无统计学差异且特异度83.8%与DWI相近,诊断准确率最高达91.9%。结论认为DCE-MRI仍不可或缺,DWI不应作为独立参数使用。

要点

  • DCE-MRI对乳腺癌检测平均敏感度100%,DWI仅82%(P<0.001),DWI不应作为独立参数。
  • DWI特异度86.8%高于DCE-MRI的76.6%(P=0.002),诊断准确率DWI 83.7%、DCE-MRI 90.6%。
  • mpMRI敏感度96.8%与DCE-MRI无统计学差异(P=0.12),准确率最高达91.9%。

核心结论

  • DCE-MRI对乳腺癌检测最敏感因而仍不可或缺;DCE-MRI联合DWI的mpMRI保持高敏感度、提高特异度并最大化诊断准确率,常可避免不必要的乳腺活检;DWI不应作为独立参数使用,因其检出的癌症显著少于DCE-MRI和mpMRI。

研究设计与样本

  • 经机构审查委员会批准的单中心研究,回顾性分析2010年12月至2014年9月因影像异常(BI-RADS 0、4/5)行乳腺MRI的106例患者的前瞻性采集数据,由4名阅片者独立评估DWI、DCE及两者联合的mpMRI,以组织病理为金标准。

诊断标准与关键数值

  • 106例患者中恶性69个、良性41个肿瘤,4例为双侧病变;DCE-MRI平均敏感度100%,DWI敏感度82%(P<0.001);DWI特异度86.8%高于DCE-MRI的76.6%(P=0.002);诊断准确率DWI 83.7%、DCE-MRI 90.6%;mpMRI敏感度96.8%(与DCE-MRI比较P=0.12)、特异度83.8%(与DWI比较P=0.195)、诊断准确率91.9%;DWI与DCE-MRI鉴别良恶性病灶的阅片者间一致性分别为κ=0.864和κ=0.875。

临床应用与阅片要点

  • 作者认为DCE-MRI对乳腺癌检测最敏感因而仍不可或缺;作者认为DCE-MRI联合DWI的mpMRI保持高敏感度、提高特异度并最大化诊断准确率,常可避免不必要的乳腺活检;作者认为DWI不应作为独立参数使用。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: The aims of this study were to compare dynamic contrast-enhanced (DCE) magnetic resonance imaging (MRI) with diffusion-weighted imaging (DWI) with apparent diffusion coefficient mapping as a stand-alone parameter without any other supportive sequence for breast cancer detection and to assess its combination as multiparametric MRI (mpMRI) of the breast.

MATERIALS AND METHODS: In this institutional review board-approved single-center study, prospectively acquired data of 106 patients who underwent breast MRI from 12/2010 to 09/2014 for an imaging abnormality (Breast Imaging Reporting and Data System 0, 4/5) were retrospectively analyzed. Four readers independently assessed DWI and DCE as well as combined as mpMRI. Breast Imaging Reporting and Data System categories, lesion size, and mean apparent diffusion coefficient values were recorded. Histopathology was used as the gold standard. Appropriate statistical tests were used to compare diagnostic values.

RESULTS: There were 69 malignant and 41 benign tumors in 106 patients. Four patients presented with bilateral lesions. Dynamic contrast-enhanced MRI was the most sensitive test for breast cancer detection, with an average sensitivity of 100%. Diffusion-weighted imaging alone was less sensitive (82%; P < 0.001) but more specific than DCE-MRI (86.8% vs 76.6%; P = 0.002). Diagnostic accuracy was 83.7% for DWI and 90.6% for DCE-MRI. Multiparametric MRI achieved a sensitivity of 96.8%, not statistically different from DCE-MRI (P = 0.12) and with a similar specificity as DWI (83.8%; P = 0.195), maximizing diagnostic accuracy to 91.9%. There was almost perfect interreader agreement for DWI (κ = 0.864) and DCE-MRI (κ = 0.875) for differentiation of benign and malignant lesions.

CONCLUSION: Dynamic contrast-enhanced MRI is most sensitive for breast cancer detection and thus still indispensable. Multiparametric MRI using DCE-MRI and DWI maintains a high sensitivity, increases specificity, and maximizes diagnostic accuracy, often preventing unnecessary breast biopsies. Diffusion-weighted imaging should not be used as a stand-alone parameter because it detects significantly fewer cancers in comparison with DCE-MRI and mpMRI.

来源:Invest Radiol,查看原文。版权归原作者所有。

引用

  1. Pinker K, Moy L, Sutton EJ, et al. Diffusion-Weighted Imaging With Apparent Diffusion Coefficient Mapping for Breast Cancer Detection as a Stand-Alone Parameter: Comparison With Dynamic Contrast-Enhanced and Multiparametric Magnetic Resonance Imaging. Invest Radiol. 2018. PMID: 29620604. doi:10.1097/RLI.0000000000000465

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。